AMRI board approves new $10 million share repurchase program

AMRI (NASDAQ: AMRI) today announced that its board of directors has approved a new share repurchase program of up to $10 million. Under the program, the company is authorized to repurchase outstanding shares of its Common Stock in the open market or in private transactions. Shares may be repurchased from time to time and in such amounts as market conditions warrant, subject to price ranges set by management and regulatory considerations.

“This program underscores our confidence in AMRI's business and our commitment to returning value to our shareholders”

"This program underscores our confidence in AMRI's business and our commitment to returning value to our shareholders," said AMRI Chairman and CEO Thomas E. D'Ambra, Ph.D. "We believe that current share price levels represent an attractive investment, particularly in view of the many longer term strategic initiatives AMRI has undertaken over the past six months. The size of the program announced today still positions the company with the financial resources and flexibility to evaluate further growth opportunities as they arise."

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.